Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway, The FASEB Journal, June 2019, Federation of American Societies For Experimental Biology (FASEB),
DOI: 10.1096/fj.201802619rr.
You can read the full text:

Read

Contributors

The following have contributed to this page